Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex versus neostigmine reversal in lower extremity surgery
ACTRN12614000553673Phase 4Recruiting
- Sponsor
- Firat University Scientific Research Projects Unit
- Start
- Jan 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Sugammadex, neostigmine, atropine and rocuronium in None (2 arms), sponsored by Firat University Scientific Research Projects Unit. Primary endpoints: Serum aldosterone, Free testosterone and 2 more. Started Jan 2014; status: recruiting.
02
Drugs
Sugammadexneostigmineatropinerocuronium
Beyond the preview
Go deeper on ACTRN12614000553673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000553673.